Octapharma Announces Final Data from Study on the Immunogenicity in Previously Untreated Patients with Severe Hemophilia A
The following is an excerpt from a press release from Octapharma. Read the full press release here. Octapharma announced the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients with severe hamophilia A have been published in the medical journal Thrombosis and Haemostasis (Liesner RJ et al. “Simoctocog Alfa […]
Dear Addy: Diversity and Inclusion
Hemophilia Federation of America is excited to now offer video responses to Dear Addy questions. While the United States grapples with issues of diversity, equity and inclusion, and improvements have been made throughout the country, a community member inquired what HFA is doing to address diversity, equity and inclusion.Senior Manager of Policy and Advocacy, Kimberly Ramseur, […]
English 
Español de Puerto Rico